The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(3-(4-hexylphenyl)-1,2,4-oxadiazol-5-yl)azetidine-1-carboximidamide hydrochloride ID: ALA3627772
Chembl Id: CHEMBL3627772
PubChem CID: 122192893
Max Phase: Preclinical
Molecular Formula: C18H26ClN5O
Molecular Weight: 327.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCc1ccc(-c2noc([C@@H]3CCN3C(=N)N)n2)cc1.Cl
Standard InChI: InChI=1S/C18H25N5O.ClH/c1-2-3-4-5-6-13-7-9-14(10-8-13)16-21-17(24-22-16)15-11-12-23(15)18(19)20;/h7-10,15H,2-6,11-12H2,1H3,(H3,19,20);1H/t15-;/m0./s1
Standard InChI Key: ZFDBMAQVTGRRFB-RSAXXLAASA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 327.43Molecular Weight (Monoisotopic): 327.2059AlogP: 3.50#Rotatable Bonds: 7Polar Surface Area: 92.03Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 11.11CX LogP: 4.50CX LogD: 2.03Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.46Np Likeness Score: -0.84
References 1. Congdon MD, Childress ES, Patwardhan NN, Gumkowski J, Morris EA, Kharel Y, Lynch KR, Santos WL.. (2015) Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors., 25 (21): [PMID:25862200 ] [10.1016/j.bmcl.2015.03.041 ]